会員登録
ログイン
【4507】塩野義製薬
製薬。感染症、疼痛・中枢神経、抗HIV。
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
| 決算期 | 日付 | 予・実 | 売上高 (百万円) |
対前回 | 修正率 | 修正率 | 営業利益 (百万円) |
対前回 | 修正率 | 修正率 | 経常利益 (百万円) |
対前回 | 修正率 | 修正率 | 当期利益 (百万円) |
対前回 | 修正率 | 修正率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025.03 | 2024/10/28 | Q2予 | 460,000 | ↑ | +1.1% | +1.1% | 165,000 | ↑ | +3.1% | +3.1% | 206,000 | ↑ | +3.0% | +3.0% | 171,000 | ↑ | +4.9% | +4.9% |
| 2025.03 | 2024/07/29 | Q1予 | 455,000 | → | 0.0% | 0.0% | 160,000 | → | 0.0% | 0.0% | 200,000 | → | 0.0% | 0.0% | 163,000 | → | 0.0% | 0.0% |
| 2025.03 | 2024/05/13 | 当初予 | 455,000 | - | - | - | 160,000 | - | - | - | 200,000 | - | - | - | 163,000 | - | - | - |
| 2024.03 | 2024/05/13 | 実 | 435,081 | ↓ | -3.3% | -3.3% | 153,310 | ↑ | +2.2% | +2.2% | 198,283 | ↑ | +3.0% | +3.0% | 162,030 | ↑ | +4.5% | +4.5% |
| 2024.03 | 2024/01/31 | Q3予 | 450,000 | → | 0.0% | 0.0% | 150,000 | → | 0.0% | 0.0% | 192,500 | → | 0.0% | 0.0% | 155,000 | → | 0.0% | 0.0% |
| 2024.03 | 2023/10/31 | Q2予 | 450,000 | → | 0.0% | 0.0% | 150,000 | → | 0.0% | 0.0% | 192,500 | → | 0.0% | 0.0% | 155,000 | → | 0.0% | 0.0% |
| 2024.03 | 2023/07/31 | Q1予 | 450,000 | → | 0.0% | 0.0% | 150,000 | → | 0.0% | 0.0% | 192,500 | → | 0.0% | 0.0% | 155,000 | → | 0.0% | 0.0% |
| 2024.03 | 2023/05/10 | 当初予 | 450,000 | - | - | - | 150,000 | - | - | - | 192,500 | - | - | - | 155,000 | - | - | - |
| 2023.03 | 2023/05/10 | 実 | 426,684 | ↑ | +4.1% | +6.7% | 149,003 | ↑ | +24.2% | +24.2% | 220,332 | ↑ | +26.6% | +31.2% | 184,965 | ↑ | +30.3% | +36.0% |
| 2023.03 | 2022/10/31 | Q2予 | 410,000 | ↑ | +2.5% | +2.5% | 120,000 | → | 0.0% | 0.0% | 174,000 | ↑ | +3.6% | +3.6% | 142,000 | ↑ | +4.4% | +4.4% |
| 2023.03 | 2022/08/01 | Q1予 | 400,000 | → | 0.0% | 0.0% | 120,000 | → | 0.0% | 0.0% | 168,000 | → | 0.0% | 0.0% | 136,000 | → | 0.0% | 0.0% |
| 2023.03 | 2022/05/11 | 当初予 | 400,000 | - | - | - | 120,000 | - | - | - | 168,000 | - | - | - | 136,000 | - | - | - |
| 2022.03 | 2022/05/11 | 実 | 335,138 | ↑ | +14.0% | +15.6% | 110,312 | ↑ | +22.6% | +22.6% | 126,268 | ↑ | +9.8% | +9.8% | 114,185 | ↑ | +14.2% | +14.2% |
| 2022.03 | 2022/01/31 | Q3予 | 294,000 | → | 0.0% | +1.4% | 90,000 | → | 0.0% | 0.0% | 115,000 | → | 0.0% | 0.0% | 100,000 | → | 0.0% | 0.0% |
| 2022.03 | 2021/11/01 | Q2予 | 294,000 | ↑ | +1.4% | +1.4% | 90,000 | → | 0.0% | 0.0% | 115,000 | → | 0.0% | 0.0% | 100,000 | → | 0.0% | 0.0% |
| 2022.03 | 2021/08/02 | Q1予 | 290,000 | → | 0.0% | 0.0% | 90,000 | → | 0.0% | 0.0% | 115,000 | → | 0.0% | 0.0% | 100,000 | → | 0.0% | 0.0% |
| 2022.03 | 2021/05/10 | 当初予 | 290,000 | - | - | - | 90,000 | - | - | - | 115,000 | - | - | - | 100,000 | - | - | - |
| 2021.03 | 2021/05/10 | 実 | 297,177 | ↓ | -1.4% | -8.1% | 117,438 | ↓ | -4.4% | +6.5% | 143,018 | ↓ | -4.2% | +4.9% | 111,858 | ↓ | -1.6% | +8.0% |
| 2021.03 | 2021/02/01 | Q3予 | 301,400 | ↓ | -5.2% | -6.8% | 122,900 | ↓ | -7.7% | +11.4% | 149,300 | ↓ | -6.5% | +9.5% | 113,700 | ↓ | -5.0% | +9.7% |
| 2021.03 | 2020/10/30 | Q2予 | 318,100 | ↓ | -1.7% | -1.7% | 133,200 | ↑ | +20.8% | +20.8% | 159,600 | ↑ | +17.1% | +17.1% | 119,700 | ↑ | +15.5% | +15.5% |
| 2021.03 | 2020/07/31 | Q1予 | 323,500 | → | 0.0% | 0.0% | 110,300 | → | 0.0% | 0.0% | 136,300 | → | 0.0% | 0.0% | 103,600 | → | 0.0% | 0.0% |
| 2021.03 | 2020/06/24 | 当初予 | 323,500 | - | - | - | 110,300 | - | - | - | 136,300 | - | - | - | 103,600 | - | - | - |
| 2020.03 | 2020/06/24 | 実 | 333,371 | ↓ | -0.5% | -8.8% | 130,628 | ↑ | +4.3% | -11.1% | 158,516 | ↑ | +4.5% | -7.0% | 122,193 | ↑ | +0.7% | -8.1% |
| 2020.03 | 2020/05/11 | 実 | 334,958 | ↓ | -5.6% | -8.4% | 125,231 | ↓ | -11.5% | -14.8% | 151,751 | ↓ | -9.1% | -11.0% | 121,295 | ↓ | -8.8% | -8.8% |
| 2020.03 | 2020/02/03 | Q3予 | 355,000 | ↓ | -3.3% | -2.9% | 141,500 | ↓ | -5.7% | -3.7% | 167,000 | ↓ | -2.6% | -2.1% | 133,000 | ↓ | -1.5% | 0.0% |
| 2020.03 | 2019/10/30 | Q2予 | 367,000 | ↑ | +0.4% | +0.4% | 150,000 | ↑ | +2.0% | +2.0% | 171,500 | ↑ | +0.6% | +0.6% | 135,000 | ↑ | +1.5% | +1.5% |
| 2020.03 | 2019/07/29 | Q1予 | 365,500 | → | 0.0% | 0.0% | 147,000 | → | 0.0% | 0.0% | 170,500 | → | 0.0% | 0.0% | 133,000 | → | 0.0% | 0.0% |
| 2020.03 | 2019/05/09 | 当初予 | 365,500 | - | - | - | 147,000 | - | - | - | 170,500 | - | - | - | 133,000 | - | - | - |
| 2019.03 | 2019/05/09 | 実 | 363,721 | ↑ | +2.7% | +5.0% | 138,537 | ↑ | +11.3% | +16.4% | 166,575 | ↑ | +12.2% | +19.0% | 132,759 | ↑ | +12.0% | +19.6% |
| 2019.03 | 2019/01/31 | Q3予 | 354,000 | → | 0.0% | +2.2% | 124,500 | → | 0.0% | +4.6% | 148,500 | → | 0.0% | +6.1% | 118,500 | → | 0.0% | +6.8% |
| 2019.03 | 2018/10/29 | Q2予 | 354,000 | ↑ | +1.7% | +2.2% | 124,500 | ↑ | +3.8% | +4.6% | 148,500 | ↑ | +3.1% | +6.1% | 118,500 | ↑ | +3.5% | +6.8% |
| 2019.03 | 2018/07/30 | Q1予 | 348,000 | ↑ | +0.4% | +0.4% | 120,000 | ↑ | +0.8% | +0.8% | 144,000 | ↑ | +2.9% | +2.9% | 114,500 | ↑ | +3.2% | +3.2% |
| 2019.03 | 2018/05/09 | 当初予 | 346,500 | - | - | - | 119,000 | - | - | - | 140,000 | - | - | - | 111,000 | - | - | - |
| 2018.03 | 2018/05/09 | 実 | 344,667 | ↓ | -0.1% | +1.4% | 115,219 | ↑ | +1.5% | +2.4% | 138,692 | ↑ | +5.1% | +12.3% | 108,866 | ↑ | +7.8% | +18.3% |
| 2018.03 | 2018/02/05 | Q3予 | 345,000 | → | 0.0% | +1.5% | 113,500 | → | 0.0% | +0.9% | 132,000 | → | 0.0% | +6.9% | 101,000 | → | 0.0% | +9.8% |
| 2018.03 | 2017/10/30 | Q2予 | 345,000 | ↑ | +1.5% | +1.5% | 113,500 | ↑ | +0.9% | +0.9% | 132,000 | ↑ | +6.9% | +6.9% | 101,000 | ↑ | +9.8% | +9.8% |
| 2018.03 | 2017/07/31 | Q1予 | 340,000 | → | 0.0% | 0.0% | 112,500 | → | 0.0% | 0.0% | 123,500 | → | 0.0% | 0.0% | 92,000 | → | 0.0% | 0.0% |
| 2018.03 | 2017/05/10 | 当初予 | 340,000 | - | - | - | 112,500 | - | - | - | 123,500 | - | - | - | 92,000 | - | - | - |
| 2017.03 | 2017/05/10 | 実 | 338,890 | ↑ | +1.5% | +6.6% | 108,178 | ↑ | +11.0% | +18.2% | 123,031 | ↑ | +16.6% | +21.2% | 83,879 | ↑ | +10.4% | +18.1% |
| 2017.03 | 2017/02/02 | Q3予 | 334,000 | → | 0.0% | +5.0% | 97,500 | → | 0.0% | +6.6% | 105,500 | → | 0.0% | +3.9% | 76,000 | → | 0.0% | +7.0% |
| 2017.03 | 2016/10/31 | Q2予 | 334,000 | ↑ | +5.0% | +5.0% | 97,500 | ↑ | +6.6% | +6.6% | 105,500 | ↑ | +3.9% | +3.9% | 76,000 | ↑ | +7.0% | +7.0% |
| 2017.03 | 2016/08/01 | 当初予 | 318,000 | - | - | - | 91,500 | - | - | - | 101,500 | - | - | - | 71,000 | - | - | - |
| 2016.03 | 2016/05/11 | 実 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 2016.03 | 2016/02/01 | Q3予 | 301,500 | → | 0.0% | +1.9% | 78,000 | → | 0.0% | +7.6% | 88,000 | → | 0.0% | +10.7% | 59,000 | → | 0.0% | +13.5% |
| 2016.03 | 2015/10/29 | Q2予 | 301,500 | ↑ | +1.9% | +1.9% | 78,000 | ↑ | +7.6% | +7.6% | 88,000 | ↑ | +10.7% | +10.7% | 59,000 | ↑ | +13.5% | +13.5% |
| 2016.03 | 2015/08/03 | Q1予 | 296,000 | → | 0.0% | 0.0% | 72,500 | - | - | - | 79,500 | → | 0.0% | 0.0% | 52,000 | → | 0.0% | 0.0% |
| 2016.03 | 2015/05/11 | 当初予 | 296,000 | - | - | - | - | - | - | - | 79,500 | - | - | - | 52,000 | - | - | - |
| 2015.03 | 2015/05/11 | 実 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 2015.03 | 2015/04/22 | 修正予 | 273,500 | → | 0.0% | +1.7% | - | - | - | - | 77,800 | ↑ | +34.1% | +55.6% | 44,000 | ↑ | +46.7% | +33.3% |
| 2015.03 | 2015/02/02 | Q3予 | 273,500 | → | 0.0% | +1.7% | 49,500 | → | 0.0% | +10.0% | 58,000 | → | 0.0% | +16.0% | 30,000 | → | 0.0% | -9.1% |
| 2015.03 | 2014/10/29 | Q2予 | 273,500 | ↑ | +1.7% | +1.7% | 49,500 | ↑ | +10.0% | +10.0% | 58,000 | ↑ | +16.0% | +16.0% | 30,000 | ↓ | -9.1% | -9.1% |
| 2015.03 | 2014/08/01 | Q1予 | 269,000 | → | 0.0% | 0.0% | 45,000 | → | 0.0% | 0.0% | 50,000 | → | 0.0% | 0.0% | 33,000 | → | 0.0% | 0.0% |
| 2015.03 | 2014/05/09 | 当初予 | 269,000 | - | - | - | 45,000 | - | - | - | 50,000 | - | - | - | 33,000 | - | - | - |
| 2014.03 | 2014/05/09 | 実 | 289,717 | - | - | - | 63,556 | - | - | - | 63,906 | - | - | - | 41,831 | - | - | - |
